Eight Steps to Successful Oncology Drug Development
Some biopharma companies are beginning to question whether oncology is still an attractive therapeutic area in which to invest. The simple answer to this, write Matthew Cook and Sebastien Morisot, is yes. Here the authors provide eight key ingredients for a successful oncology drug development recipe ...Read more |
Gravity Shift: What Can Multinationals Learn from Generic Companies?
Asia could well become the biggest pharmaceutical market and will look radically different in the medium-term. In the last three decades, MNCs have contributed greatly to the transfer of knowledge to generic companies in the region. But now its time for MNCs to learn from the generics, writes Nadeem Rehmat ... Read more
|
Pharma MBAs: A Look at the Courses on Offer
Read this and other professional training articles in the new Pharm Exec Global Digest. Also this month: Digital training for pharma executives; GMP and GDP training for biopharma; multichannel marketing; and more ... Read more
|
What’s Real in Deals
Pharm Exec recently considered the state of M&A with our thought leadership partner, Campbell Alliance, and 15 business development experts. The Roundtable discussion showed a fine appreciation of how today's business performance targets keep moving ... Read more
|
Pharm Exec’s Brand of the Year
Pharm Exec's Brand of the Year recipients for 2014 are a mainstay treatment for multiple sclerosis, and — lest we be accused of being safely predictable — we also focus on clinical and marketing achievement for an orphan-status rare disease drug ... Read more
|
Genpact to Acquire Regulatory Affairs Company
Global business process and operations company Genpact is to acquire Pharmalink Consulting. The acquisition will complement Genpact’s portfolio of life sciences services and add consulting, outsourcing and operations to its capabilities ... Read more
|
|
|
